help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammad, H.
Right arrow Articles by Lambrecht, B. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammad, H.
Right arrow Articles by Lambrecht, B. N.
(American Journal of Pathology. 2004;164:263-271.)
© 2004 American Society for Investigative Pathology

Activation of Peroxisome Proliferator-Activated Receptor-{gamma} in Dendritic Cells Inhibits the Development of Eosinophilic Airway Inflammation in a Mouse Model of Asthma

Hamida Hammad*, Hendrik Jan de Heer*, Thomas Soullié*, Véronique Angeli{dagger}, François Trottein{dagger}, Henk C. Hoogsteden* and Bart N. Lambrecht*

From the Department of Pulmonary Medicine,* Erasmus Medical Center, Rotterdam, The Netherlands; and INSERM U547,{dagger} Institut Pasteur de Lille, Lille, France

Peroxisome proliferator-activated receptors (PPARs) are activated by an array of polyunsaturated fatty acid derivatives, oxidized fatty acids, and phospholipids and are proposed to be important modulators of immune and inflammatory responses. Recently, we showed that activation of PPAR-{gamma} alters the maturation process of dendritic cells (DCs), the most potent antigen-presenting cells. In the present report, we investigated the possibility that, by targeting DCs, PPAR-{gamma} activation may be involved in the regulation of the pulmonary immune response to allergens. Using a model of sensitization, based on the intratracheal transfer of ovalbumin (OVA)-pulsed DCs, we show that rosiglitazone, a selective PPAR-{gamma} agonist, reduces the proliferation of Ag-specific T cells in the draining mediastinal lymph nodes but, surprisingly enough, dramatically increases the production of the immunoregulatory cytokine interleukin (IL)-10 by T cells, as compared to control mice sensitized with OVA-pulsed DCs. After aerosol challenge, the recruitment of eosinophils in the bronchoalveolar lavage fluids was strongly reduced compared to control mice. Finally, T cells from the mediastinal lymph nodes produced higher amounts of IL-10 and interferon-{gamma}. Inhibition of IL-10 activity with anti-IL-10R antibodies partly restored the inflammation. The specificity of the phenomenon was confirmed by treating OVA-pulsed DCs with ciglitazone, another PPAR-{gamma} agonist, and by using GW9662, a PPAR-{gamma} antagonist. Our data suggest that PPAR-{gamma} activation prevents induction of Th2-dependent eosinophilic airway inflammation and might contribute to immune homeostasis in the lung.





This article has been cited by other articles:


Home page
ChestHome page
M. G. Belvisi and D. J. Hele
Peroxisome Proliferator-Activated Receptors as Novel Targets in Lung Disease
Chest, July 1, 2008; 134(1): 152 - 157.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Miksa, R. Wu, X. Cui, W. Dong, P. Das, H. H. Simms, T. S. Ravikumar, and P. Wang
Vasoactive Hormone Adrenomedullin and Its Binding Protein: Anti-Inflammatory Effects by Up-Regulating Peroxisome Proliferator-Activated Receptor-{gamma}
J. Immunol., November 1, 2007; 179(9): 6263 - 6272.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Marathe and P. Tontonoz
Linking metabolism to immunity through PPAR{gamma}
Blood, November 1, 2007; 110(9): 3092 - 3093.
[Full Text] [PDF]


Home page
J. Immunol.Home page
E. A. Wohlfert, F. C. Nichols, E. Nevius, and R. B. Clark
Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) and Immunoregulation: Enhancement of Regulatory T Cells through PPAR{gamma}-Dependent and -Independent Mechanisms
J. Immunol., April 1, 2007; 178(7): 4129 - 4135.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Hontecillas and J. Bassaganya-Riera
Peroxisome Proliferator-Activated Receptor {gamma} Is Required for Regulatory CD4+ T Cell-Mediated Protection against Colitis
J. Immunol., March 1, 2007; 178(5): 2940 - 2949.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Gogolak, B. Rethi, I. Szatmari, A. Lanyi, B. Dezso, L. Nagy, and E. Rajnavolgyi
Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPAR{gamma}
Blood, January 15, 2007; 109(2): 643 - 652.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
I. SZATMARI, E. RAJNAVOLGYI, and L. NAGY
PPAR{gamma}, a Lipid-Activated Transcription Factor as a Regulator of Dendritic Cell Function
Ann. N.Y. Acad. Sci., November 1, 2006; 1088(1): 207 - 218.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. M. Simon, M. C. Arikan, S. Srisuma, S. Bhattacharya, L. W. Tsai, E. P. Ingenito, F. Gonzalez, S. D. Shapiro, and T. J. Mariani
Epithelial cell PPAR{gamma} contributes to normal lung maturation
FASEB J, July 1, 2006; 20(9): 1507 - 1509.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Jakubzick, F. Tacke, J. Llodra, N. van Rooijen, and G. J. Randolph
Modulation of Dendritic Cell Trafficking to and from the Airways
J. Immunol., March 15, 2006; 176(6): 3578 - 3584.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. August, C. Mueller, V. Weaver, T. A. Polanco, E. R. Walsh, and M. T. Cantorna
Nutrients, Nuclear Receptors, Inflammation, Immunity Lipids, PPAR, and Allergic Asthma
J. Nutr., March 1, 2006; 136(3): 695 - 699.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. R. Kim, K. S. Lee, H. S. Park, S. J. Park, K. H. Min, S. M. Jin, and Y. C. Lee
Involvement of IL-10 in Peroxisome Proliferator-Activated Receptor {gamma}-Mediated Anti-Inflammatory Response in Asthma
Mol. Pharmacol., December 1, 2005; 68(6): 1568 - 1575.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Wang, R. Han, I. Lee, A. S. Hancock, G. Xiong, M. D. Gunn, and W. W. Hancock
Permanent Survival of Fully MHC-Mismatched Islet Allografts by Targeting a Single Chemokine Receptor Pathway
J. Immunol., November 15, 2005; 175(10): 6311 - 6318.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. J. Henry, A. D'Aprile, G. Self, T. Hong, and T. S. Mann
Inhibitors of Prostaglandin Transport and Metabolism Augment Protease-Activated Receptor-2-Mediated Increases in Prostaglandin E2 Levels and Smooth Muscle Relaxation in Mouse Isolated Trachea
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 995 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Fainaru, D. Shseyov, S. Hantisteanu, and Y. Groner
Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease
PNAS, July 26, 2005; 102(30): 10598 - 10603.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Visser, H. Jan de Heer, L. A. Boven, D. van Riel, M. van Meurs, M.-J. Melief, U. Zahringer, J. van Strijp, B. N. Lambrecht, E. E. Nieuwenhuis, et al.
Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease
J. Immunol., January 15, 2005; 174(2): 808 - 816.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.